AKT1 and deep vein thrombosis: [26] have shown that PI3K/AKT phosphorylation is significantly associated with platelet activation in severe COVID-19 patients, suggesting that the inhibition of PI3K/AKT phosphorylation may be a promising strategy to prevent the onset of thrombosis in COVID-19 patients.